Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CAMP
- Price
- 1.78
- Stock movement down
- -0.22 (-11.00%)
- Company name
- CAMP4 THERAPEUTICS CORPORATION
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- -
- Ent value
- 164.45M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -75.04%
- 3 year return
- -80.46%
- 5 year return
- -62.69%
- 10 year return
- -42.39%
Last updated: 2025-04-14
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CAMP does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | 1.43 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 115.34M |
| Gross profit (TTM) | 39.92M |
| Operating income (TTM) | -86.63M |
| Net income (TTM) | -89.23M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 34.61% |
| Operating margin (TTM) | -75.11% |
| Profit margin (TTM) | -77.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.61M |
| Net receivables | 0.00 |
| Total current assets | 14.79M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 17.05M |
| Total assets | 29.94M |
| Accounts payable | 1.46M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 7.79M |
| Total liabilities | 177.06M |
| Shareholder's equity | -147.11M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 8.97M |
| Capital expenditures (TTM) | 4.22M |
| Free cash flow (TTM) | -1.04M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -297.99% |
| Return on Invested Capital | 60.65% |
| Cash Return on Invested Capital | 0.71% |
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.10 |
| Daily high | 2.32 |
| Daily low | 1.76 |
| Daily Volume | 41K |
| All-time high | 1362.75 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CAMP | S&P500 | |
| Current price drop from All-time high | -99.87% | -12.04% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 12 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -72.26% | -11.07% |
| Avg time to new high | 50 days | 12 days |
| Max time to new high | 6096 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Employees
58
Website
Investor relations
-
SEC filings
CEO
Jeffery R. Gardner
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner